Description
Recombinant monoclonal antibody to PDL2. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma Z64P2D3*H4.
Target
PDL2
Target Alias Names
CD273, Programmed cell death 1 ligand 2, PD-1 ligand 2, PD-L2, PDL-2, Butyrophilin B7-DC, B7-DC
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression